Andersons pediatric cardiology 345
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.76 KB, 3 trang )
ductusarteriosus.Lancet(London,England).
1995;346(8969):255.
151.MoscaF,BrayM,LattanzioM,FumagalliM,
TosettoC.Comparativeevaluationoftheeffects
ofindomethacinandibuprofenoncerebral
perfusionandoxygenationinpreterminfants
withpatentductusarteriosus.JPediatr.
1997;131(4):549–554.
152.AhlforsCE.Effectofibuprofenonbilirubinalbuminbinding.JPediatr.2004;144(3):386–
388.
153.ThibautC,HazardA,HuonC,DesfrereL.Effect
ofibuprofenonbilirubin-albuminbinding
duringthetreatmentofpatentductusarteriosus
inpreterminfant.Thejournalofmaternal-fetal
&neonatalmedicine:theofficialjournalofthe
EuropeanAssociationofPerinatalMedicine,the
FederationofAsiaandOceaniaPerinatal
Societies,theInternationalSocietyofPerinatal
Obstet.2011;24(suppl3):7–9.
154.OncelMY,YurttutanS,ErdeveO,etal.Oral
paracetamolversusoralibuprofeninthe
managementofpatentductusarteriosusin
preterminfants:arandomizedcontrolledtrial.J
Pediatr.2014;164(3):510–514[e1].
155.DangD,WangD,ZhangC,etal.Comparisonof
oralparacetamolversusibuprofeninpremature
infantswithpatentductusarteriosus:a
randomizedcontrolledtrial.PLoSONE.
2013;8(11):e77888.
156.WeiszDE,MartinsFF,NieldLE,etal.
Acetaminophentoavoidsurgicalligationin
extremelylowgestationalageneonateswith
persistenthemodynamicallysignificantpatent
ductusarteriosus.Journalofperinatology:
officialjournaloftheCaliforniaPerinatal
Association.2016;36(8):649–653.
157.TerrinG,ConteF,OncelMY,etal.Paracetamol
forthetreatmentofpatentductusarteriosusin
pretermneonates:asystematicreviewandmetaanalysis.ArchDisChildFetalNeonatalEd.
2016;101(2):F127–F136.
158.Leon-WyssJ,VidaVL,VerasO,etal.Modified
extrapleuralligationofpatentductusarteriosus:
aconvenientsurgicalapproachinadeveloping
country.AnnThoracSurg.2005;79(2):632–635.
159.SimEW,WongML,LingLH,SalimS,Chan
WX.Videothoracoscopicligationofpatent
ductusarteriosus–acasereport.AnnAcadMed
Singapore.1996;25(5):728–729.
160.RadtkeWA.Currenttherapyofthepatentductus
arteriosus.CurrOpinCardiol.1998;13(1):59–
65.
161.PalderSB,SchwartzMZ,TysonKR,MarrCC.
Managementofpatentductusarteriosus:a
comparisonofoperativevpharmacologic
treatment.JPediatrSurg.1987;22(12):1171–
1174.
162.CassadyG,CrouseDT,KirklinJW,etal.A
randomized,controlledtrialofveryearly
prophylacticligationoftheductusarteriosusin
babieswhoweighed1000gorlessatbirth.N
EnglJMed.1989;320(23):1511–1516.
163.KabraNS,SchmidtB,RobertsRS,etal.
Neurosensoryimpairmentaftersurgicalclosure
ofpatentductusarteriosusinextremelylow
birthweightinfants:resultsfromthetrialof
indomethacinprophylaxisinpreterms.JPediatr.
2007;150(3):229–234[34.e1].
164.MadanJC,KendrickD,HagadornJI,FrantzID
3rd.Patentductusarteriosustherapy:impacton
neonataland18-monthoutcome.Pediatrics.
2009;123(2):674–681.
165.WeiszDE,MireaL,RosenbergE,etal.
Associationofpatentductusarteriosusligation
withdeathorneurodevelopmentalimpairment
amongextremelypreterminfants.JAMA
pediatrics.2017;171(5):443–449.
166.TeixeiraLS,ShivanandaSP,StephensD,Van
ArsdellG,McNamaraPJ.Postoperative
cardiorespiratoryinstabilityfollowingligationof
